| Tag | Content |
|---|
EnhancerAtlas ID | HS101-03159 |
Organism | Homo sapiens |
Tissue/cell | HT29 |
Coordinate | chr1:169552940-169555460 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXC1 | MA0032.2 | chr1:169555347-169555358 | ATATTTACTTA | - | 6.14 | | TP63 | MA0525.2 | chr1:169553908-169553926 | GACAAGTTAGAACAAGTT | - | 6.02 | | TP63 | MA0525.2 | chr1:169553908-169553926 | GACAAGTTAGAACAAGTT | + | 6.58 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_35631 | chr1:169551838-169556666 | HepG2 | | SE_59161 | chr1:169550193-169574835 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr1 | 169554315 | 169554804 | | chr1 | 169554120 | 169554345 | | chr1 | 169553917 | 169554291 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I169584 | chr1 | 169553839 | 169556238 |
|
Enhancer Sequence | TTCAGGTTTT CTCAGAAAGC AAAAACAAAT CTGTAGTTAC AGTAATGCTC ACAAATTGTA 60
ATATGTGGAA TACAGAAACT GTGTTAATAT GTGGGGGCAG AATTAAAGGA GGCACGTAAG 120
TACTTTTAGA ATAGCTAGAT AGAGAAGGTA GTGGATTCTC CATCACTGGA AGCATTCAAG 180
TAGAAATTAG ACAACTACTT GGTAAGGTCA TTGGTGCTGA GGGAAAGGGG AAAAGTAGAA 240
GGTTAAAGCG TGGAAGTTGA ATATGAATTA AATGAACTCT TAGCATTCTT CTAACTTAAG 300
AATTCCAGGA TTCTATATAC TAATGTCCCT AATGTGGAAG TCCATTTTTA TTTATTTATT 360
TTTAGTACAA TTGAAAAGTT ATTGTCCTCC CCTGCCCCAG ATCTTTAATA CAGAAATGTA 420
GATGATGGTG TAAAATCTTT ACTAAAAAAT ATCAGTCTCT TACGTGGAGT AATTTCAACA 480
GAGAGATGTT TCCTAACATG TTTTTACTAT GTATGCTGTG TATTCATACT GAGGTATGTC 540
TATTTTGATC TGAACAATTT CTATTGGAAA ATAATCTATC TGATTAAAAA GTTACAGATC 600
ATATGAATTC AAACAATGTG TACGACGAGT TTTTCATTTA TAAGGATTGT TTAAAGATGA 660
TTTGTTCATA ATCACAAAAT CATATAAAGC TAGAACCCTA GAAGGAAAAT GTATGTATAT 720
CTTTTCTTCA ATATCTCTTT GTATACATGT GAGTGACTAA ACAAGTTTTC TAAGGAAATT 780
TTTGAAAGTG TTCACCTTAG ACTTGGAGCA AGAATAATAG ATACATTTTA CCTTTAAAAG 840
GCATTGTCCT GCTAATATTA TATGAAATAA GTAGATAGAT GTCTGCTTTG TGCTAAAATA 900
CACTTTGCCA AAAGATGGAG TTGGCTATGT TGATATTCAC CTAGTGAGTA TCATAGCTCT 960
AGGGGCAGGA CAAGTTAGAA CAAGTTCTTA GTTTAAGCAG CCAGATATAT GGATTAGATT 1020
TTTCATAAGA AAATGCTAGA GAGAAATGAT ATGATTTAGG GTTAAACAAT ATGACAGTTT 1080
GTCTGGGTTG TGTTTCTATG GTTTTGACTC AACAATTCCT ACCAGAGGAA CGAATCTCCA 1140
GAACTTTGGA AACTTACCCA CAGGATGAGG GGACAGAATG ACCAGTCATG GTTCCCTGTG 1200
TACTCACCAT GTGAATCAGA CCTTTGCCCT ATCTGGTTCT GCCTCCGGTA TTTTGCTTGT 1260
TATTTTCAAC GCTAACTACA GACAAGAGAA AAAACTCCCA AGCATGAACC CAGCATGCTA 1320
CAAGAAAGCC AACAACCAAG TCTGCATTCT ACTCATGAGC AGGCAAGATT AGTGTTAGAA 1380
GGACTGTTAT TTTCCTTGGG GTTTTAGCTT ACGGCAGTTC CCAAAGGGTG TGGGTGTGAC 1440
CTAGATTATC ACTTTGAAGT ACGATATTTA AAATGATTAT TTTTGAGAAG GAGGGATCTC 1500
TTCTTATTAT AAGACCAAGA TGGTATGTAA TACCCTCCAA AATAACCCAG TTACAATGAG 1560
AGTTTTAAAA AGGTTAATAT TATACACTAA AAGATCTCAA AATATTACAT TATTTTTTGG 1620
CAGATTACTT TGGTTTTGTA ATTGTAAAAG AGGAACACAT CTTTCATAAT GAAGTGTGAT 1680
GTAAGGAAAA AAAGTGAGTC ACACTAGCAG GTTTACCATT TAAAAAATAA CTAACTGGAA 1740
ATATTGAATA GACTGTATGA TTTAGTTAAT TTCTGAGAAG TCTTATTTTT AACATTTCAA 1800
TTAGAAAAAA TAGTTTGCAA CTCAAGGATA GTATTTTATC TGAATTAAAC CTCCTCTCAG 1860
TTACATATGC CTTTAAGTAG CCAAGGTAAA CCATATCCCA GGACATGATG AACAGAGAGA 1920
AAAAAAAATG AAGAGTCACA TTCAATAGGA TAAATAAGTC AAATATGAAG CAGAAAAAAG 1980
GTGAAAGTAC AAAAACATAC AAGAACTGAT GATATTTTGA AAGTCATTTA TAAGGCAGCA 2040
ATAAAATTAT ATGACAAAAA GCACAAGGTG TTCATTTTTA GTTTTAGAAG ATGAAGCTAT 2100
GTAGACAATG GAATAAATAA TATGTAACTA GGAGTCTCAT AAAAATACTA TACAACTAAA 2160
AATCTGGAAC AGGAGTTTGC AGGAAGGGCT AATGAGGGAG CAAGTGCCTG GTGCCTTTGA 2220
ATTAACCAAT ATATAAGCCA ACACAAACAT ACTAACAAAA CTGTATTGAA AATAAACTTG 2280
AAAAGAAGGT AGCATCTAAC CAATCAAATA GGGTGCTTTC TAAACCCTCA GAATGATAAA 2340
CTACATTGTT GGATGCAAAA TTAGCATTTG CCCAGTTTAT TTAATTCAGT ATACTCTCCT 2400
ATTAGTTATA TTTACTTACC TGAAGTTAAA AAAAAAAAAA GCCATGACAT TGCAAAGGGA 2460
ATGTTCTCTA AAAGAAATAG ATTTTCCTCT CTAGAGAAGC CCACCCGGAC TCCACACCTG 2520
|
